W12-026: Anti-immune evasive therapy in the treatment of FIP - randomized, controlled clinical trial
Hans Nauwynck & Sabine Gleich; Ghent University: $24,962
An effective therapy for feline infectious peritonitis (FIP) is not currently available and most affected cats succumb to their disease. Previous research has shown that FIP virus can evade the host's immune system and that a specific drug can act as a blocking agent to inhibit this evasion mechanism. In a previous project funded by Winn, it was shown that this drug is well tolerated when given to healthy cats. In this project, the efficacy of the drug as a treatment for FIP in 10 naturally infected cats will be evaluated. If the results of the pilot study are promising, the project will be expanded into a full trial.
Savannah Cat Chat Forum
Susan E. Gingrich & James Shurskis
Dr. Jessica Good